Stockscreener 앱 받기
228.63
0.72%
-1.65
시간 외 거래:
228.63
Insulet Corporation 주식(PODD)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet CorporationPODD - PR Newswire
PODD Investor Alert: Insulet Corp. Potential Securities - GlobeNewswire
Insulet Corporation $PODD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Alecta Tjanstepension Omsesidigt Increases Stake in Insulet Corporation $PODD - MarketBeat
PODD Investor Alert: Insulet Corp. Potential Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & Korsinsky - PR Newswire
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
FinancialContentInsulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Insulet Gains 62.9% in a Year: What's Driving the Stock? - MSN
Insulet Corp. Stock Hits Day Low of $216.51 Amid Price Pressure - Markets Mojo
Insulet Corp. Hits New 52-Week Low at $216.51 Amid Market Challenges - Markets Mojo
Volatility Watch: Can Insulet Corporation deliver alpha2026 Action & Low Risk Profit Maximizing Plans - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet ... - Bluefield Daily Telegraph
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet CorporationPODD - FinancialContent
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
ATTENTION Insulet Corporation (PODD) Investors: Possible FraudContact Levi & Korsinsky Today - The Globe and Mail
Insulet recalling certain defective Omnipod insulin delivery devices - MSN
Momentum Shift: Does Insulet Corporation stock benefit from AI growth2026 Big Picture & Community Verified Trade Alerts - baoquankhu1.vn
Insulet Corp. stock underperforms Friday when compared to competitors - MSN
Insulet Surges 2.19% as Earnings and Buys Outweigh Recall Risks Traded at 448th Volume Rank - Bitget
Insulet recalls specific Omnipod 5 insulin pump lots after injuries - Investing.com Nigeria
Insulet stock (ISIN: US45784P1012): Insulin Pump Maker Faces Competitive Pressure Amid Rising Health - AD HOC NEWS
Insulet to spend up to $40M on insulin pump recall - Worcester Business Journal
Jain Global LLC Purchases 63,719 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Stock Drops 7% After Omnipod 5 Recall - TIKR.com
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment - The Motley Fool
Cinctive Capital Management LP Makes New $6.69 Million Investment in Insulet Corporation $PODD - MarketBeat
Diabetic insulin pods recalled for manufacturing issue - NewsNation
How The Insulet (PODD) Narrative Is Shifting With Omnipod 5 And Rising Competition - Yahoo Finance
What Insulet (PODD)'s Omnipod 5 Pod Correction and Trial Data Reveal for Shareholders - Sahm
Is It Time To Reassess Insulet (PODD) After Recent Share Price Weakness - Yahoo Finance
Insulet Stock To $154? - Trefis
Why Insulet (PODD) Is Down 7.2% After Omnipod 5 Recall Over Insulin Under-Delivery Risk - Yahoo Finance
Insulet Corporation stock hits 52-week low at 226.14 USD By Investing.com - Investing.com India
Insulet Corporation (NASDAQ:PODD) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Securities Fraud Investigation Into Insulet Corporation (PODD) An - The National Law Review
Insulet recalls specific Omnipod 5 insulin pump lots after injuries By Investing.com - Investing.com Australia
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - lincolnjournal.com
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - WFXG
Insulet recalls some insulin devices in US over leakage risk - Reuters
FDA announces recall of insulin delivery pods - Cardiovascular Business
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
Insulet to spend up to $40M on Omnipod 5 pod recall - The Business Journals
Insulet Down Nearly 7%, on Track for Lowest Close Since September 2024 -- Data Talk - 富途牛牛
Insulet initiates Omnipod 5 recall following 18 AE reports - Yahoo Finance
Insulet Corporation stock hits 52-week low at 226.14 USD - Investing.com Nigeria
Insulet falls as Omnipod 5 Pod medical device correction spotlights manufacturing issue - Quiver Quantitative
Insulin devices recalled over leak risk, reports of 'serious adverse events' - LiveNOW from FOX
Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps - MedTech Dive
Insulet (NASDAQ:PODD) Sets New 12-Month LowShould You Sell? - MarketBeat
Insulet (PODD) Faces Stock Dip After Voluntary Device Correction - GuruFocus
Insulet Begins Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S. - Medical Product Outsourcing
Insulet Stock Hits 52-Week Low - Benzinga
Insulet recalling Omnipod insulin delivery units (PODD:NASDAQ) - Seeking Alpha
FourThought Financial Partners LLC Sells 5,878 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation (NASDAQ:PODD) Sees Significant Increase in Short Interest - MarketBeat
0.85%
1.86%
자본화:
|
볼륨(24시간):